Systemic lupus erythematosus (SLE) in childhood:: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

被引:188
作者
Font, J
Cervera, R
Espinosa, G
Pallarés, L
Ramos-Casals, M
Jiménez, S
García-Carrasco, M
Seisdedos, L
Ingelmo, M
机构
[1] Univ Barcelona, Hosp Clin, Sch Med, IDIBAPS,Dept Med,Syst Autoimmune Dis Unit, Barcelona 08036, Catalonia, Spain
[2] Hosp Son Dureta, Dept Internal Med, Majorca, Balearic Isl, Spain
关键词
D O I
10.1136/ard.57.8.456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To define the pattern of disease expression in patients with childhood onset systemic lupus erythematosus (SLE). Methods-Prospective analysis of clinical manifestations and immunological features of 34 patients in whom the first manifestations appeared in childhood from a series of 430 unselected patients with SLE. Results-Thirty one (91%) patients from the childhood onset group were female and three male (9%) (ratio female/male, 10/1, with no difference compared with the adult onset group). Mean age of this group at disease onset was 11 years (range 5-14) compared with 32 years (15-48) for the remaining patients. The childhood onset patients more often had nephropathy (20% v 9% in adult onset SLE, p=0.04; OR:2.7; 95%CI:1.1, 7), fever (41% v 21%, p=0.006; OR:2.6, 95%CI:1.2, 5.7), and lymphadenopathy (6% v 0.5%, p=0.03, Hospital Clinic, School OR: 12.3, 95%CI: 1.2, 127.6), as presenting of Medicine, clinical manifestations. During the evolution of of the disease, the childhood onset Barcelona, Barcelona, patients had an increased prevalence of malar rash (79% v 51%, p=0.002; OR:3.7; 95%CI:1.5, 9.5) and chorea (9% v 0%, p<0.0001). This group exhibited a higher prevalence of anticardiolipin antibodies (aCL) of the IgG isotype when compared with the remaining patients (29% v 13%, p=0.017; OR:2.9, 95%CI:1.2, 6.8). No significant differences were found among the other antibodies between the two groups. Childhood onset patients more often received azathioprine (15% v 6%, p=0.00004; OR:11.2; 95%CI:2.8, 44.9) but no differences were detected between the groups concerning side effects or drug toxicity. Conclusions-The presentation and the clinical course of SLE varied in this series of 430 patients depending on their age at disease onset. Nephropathy, fever, and lymphadenopathy were more common in childhood onset patients as presenting clinical manifestations, while malar rash, chorea, and detection of IgG aCL were more common during the evolution of the disease.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 33 条
[1]  
American Rheumatism Association Glossary Committee, 1982, SIGNS SYMPT, V1, P1
[2]  
BARRON KS, 1993, ARTHRITIS RHEUM, V3, P340
[3]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[4]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN CHILDHOOD [J].
CAEIRO, F ;
MICHIELSON, FMC ;
BERNSTEIN, R ;
HUGHES, GRV ;
ANSELL, BM .
ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (04) :325-331
[5]  
Cassidy J T, 1977, Arthritis Rheum, V20, P315
[6]   SEX-DIFFERENCES IN CHILDHOOD LUPUS NEPHRITIS [J].
CELERMAJER, DS ;
THORNER, PS ;
BAUMAL, R ;
ARBUS, GS .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1984, 138 (06) :586-588
[7]   ISOTYPE DISTRIBUTION OF ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF 100 PATIENTS [J].
CERVERA, R ;
FONT, J ;
LOPEZSOTO, A ;
CASALS, F ;
PALLARES, L ;
BOVE, A ;
INGELMO, M ;
URBANOMARQUEZ, A .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (02) :109-113
[8]   SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS [J].
CERVERA, R ;
KHAMASHTA, MA ;
FONT, J ;
SEBASTIANI, GD ;
GIL, A ;
LAVILLA, P ;
DOMENECH, I ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
DERAMON, E ;
GALEAZZI, M ;
HAGA, HJ ;
MATHIEU, A ;
HOUSSIAU, F ;
INGELMO, M ;
HUGHES, GRV ;
CERVERA, R ;
SEBASTIANI, GD ;
FONT, J ;
KHAMASHTA, MA ;
HUGHES, GRV ;
FONT, J ;
CERVERA, R ;
LOPEZSOTO, A ;
VIVANCOS, J ;
INGELMO, M ;
URBANOMARQUEZ, A ;
KHAMASHTA, MA ;
VIANNA, J ;
HUGHES, GRV ;
GIL, A ;
LAVILLA, P ;
PINTADO, V ;
LOPEZDUPLA, M ;
VAZQUEZ, JJ ;
SEBASTIANI, GD ;
DERAMON, E ;
CAMPS, M ;
FRUTOS, MA ;
PERELLO, I ;
SANTOS, PG ;
ABARCA, M ;
NEBRO, AF ;
DOMENECH, I ;
TOKGOZ, G ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
MALDYKOWA, H ;
CHWALINSKASADOWSKA, H ;
GALEAZZI, M .
MEDICINE, 1993, 72 (02) :113-124
[9]  
COSTALLAT LTL, 1994, CLIN EXP RHEUMATOL, V12, P603
[10]  
DUBOIS EL, 1964, JAMA-J AM MED ASSOC, V190, P104